Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy Gas-permeable-bioreactor-and-method-of-use

 Peptide-containing polyethylene glycol derivatives and application thereof
OF THE PREFERRED EMBODIMENTS The present invention will hereinafter be explained in more detail. T...


 Modified HIL-6
OF THE INVENTION Described below is the chemical modification with PEG of at least one amino group ...


 Construction of geometrical objects from polynucleotides
By means of the present invention, DNA, RNA and similar polymers may be produced by synthesizing a ...


 Starburst conjugates
In its broadest aspect, the present invention is directed to polymer conjugate materials comprising ...


 Intermediates for providing functional groups on the 5' end of oligonucleotides
We claim: 1. A partially protected alcohol of the formula: ##STR10## wherein Y.sup.1 is selected ...


 Antiviral polynucleotide conjugates
OF THE INVENTION The present invention provides polynucleotide conjugates characterized by the ...


 Azlactone activated polyalkylene oxides conjugated to biologically active nucleophiles
OF THE PREFERRED EMBODIMENT The azlactone activated polyalkylene oxides of the present invention ...


 Biologically compatible linear block copolymers of polyalkylene oxide and peptide units
INCLUSIVE OF PREFERRED EMBODIMENTS We have discovered that linear block copolymers comprising ...


 Electrophilic polyethylene oxides for the modification of polysaccharides, polypeptides (proteins) and surfaces
The present invention provides for compounds having the formula: ##STR1## wherein R.sub.1 is ...


 Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
OF THE INVENTION The following examples are given to illustrate the invention, but should not be ...


 Gas permeable bioreactor and method of use

Details
Inventors: Schwarz, Ray P.;
Assignee: Synthecon, Inc. (Houston, TX)
Primary Examiner: Redding; David A.
Assistant Examiner:
Attorney, Agent or Firm: Buskop; Wendy K. Chamberlain, Hrdlicka et al.

This invention relates to an apparatus and method of use for a new simply constructed bioreactor made at least partially of gas permeable materials. The bioreactor is useful for culturing cells and tissues in suspension as well as attached to the inside surface of the bioreactor in a liquid nutrient medium with minimum turbulence. The bioreactor may include ports for easy access to the vessel culture, allowing the growth substrate to be varied for optimum performance.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS Like numbered apparatus elements in FIGS.
1-11 are the same.
Referring to the drawings, FIG.
1 is a cross-sectional side view of a preferred embodiment of the gas permeable bioreactor of the present invention showing a motor assembly unit for rotation purposes.
In the preferred embodiment of the invention, the bioreactor 2 is made of a tubular vessel 4 with outer walls 24 constructed at least partially of a gas permeable material 6 defining a vessel chamber.
The outer walls 24 themselves may be constructed of the gas permeable material 6 or the material 6 may be made a part of the outer walls 24 in the same manner as the microscope viewports 50 discussed below.
The vessel 4 has closed ends 8 and a substantially horizontal longitudinal central axis 10.
One or more vessel access ports 18 are provided for transferring materials into and out of the vessel 4.
The vessel 4 in one preferred embodiment is constructed such that half of it is comprised of gas permeable material 6 and the remaining portion is made of nonpermeable material 7.
The gas permeable materials 6 commonly available are opaque.
Thus, using nonpermeable material 7 for part of the bioreactor 2 may provide an advantage in allowing visual inspection of the vessel chamber.
To further enhance oxygen absorption into the vessel chamber, depressions 22 may be formed in the outer walls 24 in areas where there is gas permeable material 6.
The thinner the outer wall 24, the less distance the oxygen must travel before entering the vessel chamber.
The gas permeable material 6 used to make the bioreactor 2 preferably is a porous, hydrophobic material.
It may be a porous nonhydrophobic material coated on one side with silicone rubber or some other hydrophobic material to achieve gas permeability.
However, if the pore size of the porous material is one micron or less, a coating is not preferred.
In the preferred embodiment, the porous material used is a "foamed" plastic, which is a hardened porous plastic



Related patents
  Method for treating diseases of the inner ear using adamantane derivatives
OF THE INVENTION As already mentioned, the use of adamantane derivatives is possible or conceivable in many cases of diseases of the inner ear. Preferably, adamantane ...
  Polyalkylene oxide-containing urethane polyols with sulphonic acid groups
What is claimed is: 1. Sulphonic acid group-containing polyalkylene oxide-containing urethane polyols corresponding to the formula: ##STR16## wherein X represents an NH....
  Herpes treatment
I claim: 1. A method for the control of herpes virus infections in man which comprises contacting the herpes lesions, topically or by injection, with a dose of L-lysine L...
  Dense star polymers and dendrimers
OF ILLUSTRATIVE EMBODIMENTS In the dense star polymers of the present invention, the core is covalently bonded to at least one core branch, preferably at least two, ...
  Glycerin derivatives and inhibition of blood PAF
OF THE INVENTION The glycerine derivatives of the invention are compounds of the formula ##STR3## wherein one of the residues R.sup.1, R.sup.2 and R.sup.3 is group U of ...
  Oligonucleotide derivatives and production thereof
Gist In view of the state of the art as described above, the present inventors have developed an immobilized oligonucleotide which is useful in purification of nucleic ...
  Process for synthesizing macrocyclic chelates
The invention is a process for synthesizing a 12 membered ring tetraaza macromolecule. The process involves condensing an amide of ethylene diamine having a general ...
  Immunoconjugates joined by thioether bonds having reduced toxicity and improved selectivity
I claim: 1. A method for producing a 1:1 protein:anitbody tioether-linked immunoconjugate as a predominant species, comprising the steps of: combining a protein selected ...
  Compositions for photodynamic therapy
I claim: 1. A pharmaceutical composition useful for photodynamic therapy which composition contains, as active ingredient, a conjugate of a porphyrin-type ...
  Amplifier molecules for enhancement of diagnosis and therapy
As used herein, an "amplifier" or "amplifier molecule" is a chemical compound having a multiplicity of terminal amine moieties, each serving as a locus to which one or ...

0.004

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved